.Welcome to recently's Chutes & Ladders, our summary of considerable management hirings, shooting...
.Vertex's attempt to address an unusual hereditary health condition has hit an additional problem. T...
.Vir Biotechnology's second-quarter earnings file had not been except big headlines. The provider we...
.Galapagos has stopped enrollment in a test of a BCMA-directed CAR-T cell treatment, pumping the bra...
.After more than three decades, genetics therapy trendsetter James Wilson M.D., Ph.D., is leaving be...
.As biotechs seek to turn a fresh webpage in August, at least 3 companies have lost team in attempts...
.Professional venture capital company venBio has lifted an additional half a billion dollars to buy ...
.Otsuka Pharmaceutical has gotten Boston-based Jnana Therapies for $800 million so the Japanese biot...
.FibroGen is significantly restructuring its own service, laying off 75% of its united state team an...
.Tracon Pharmaceuticals has actually chosen to unwind operations weeks after an injectable invulnera...